시장보고서

상품코드

1597055

유럽의 가금용 백신 시장 예측(-2031년)

Europe Poultry Vaccines Market Forecast to 2031 - Regional Analysis - by Type, Technology, Dosage Form, Disease, Route Of Administration, and End User

발행일: 2024년 10월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 153 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

유럽 가금류 백신 시장은 2023년에 3억 2,182만 달러로 평가되었고, 2031년에는 6억 3,501만 달러에 이르고, 2023년부터 2031년까지의 CAGR은 8.9%를 나타낼 것으로 예측됩니다.

가금산업의 성장이 유럽가금용 백신 시장을 견인

미국 농무부(USDA)의 보고서에 따르면, 가금류는 지난 20년간, 특히 개발도상국이나 신흥국 시장에서 세계에서 가장 소비되는 가축이 되었습니다. 향후 10년간 가금류가 세계에서 가장 큰 수입 가축 제품으로 지속될 것으로 예상됩니다. 닭고기 제품과 수입품에 대한 수요는 세계적으로 증가하고 있습니다. 특히 닭의 구입으로 이동하고 있습니다. 동남아시아와 사하라 이남의 아프리카 등, 많은 신흥 경제 국가와 신흥 시장의 급속한 도시화에 따라, 닭고기 제품은 고단백질을 포함해 고가의 다른 육류를 베이스로 하여 제품 대비 구매하기 쉽기 때문에 소비자에게 저렴한 가격으로 구매할 수있는 옵션을 제공합니다. 브라질, 유럽 연합(EU), 태국 포함, 이들은 닭고기의 주요 수출국이기도 합니다. 또한, 2001년부터 2021년에 걸쳐, 세계의 닭고기 수입량은 전년대비 평균 4% 증가로 2021년 생산량은 1,420만 톤에 달할 전망입니다. 닭고기 제품 수요가 세계적으로 높은 수준을 유지해, 각국이 가축의 국내 생산에 주력하고 있기 때문에 백신 접종 수요도 늘어나고 있습니다. 이처럼 가금 산업의 성장이 가금용 백신 시장의 성장을 뒷받침하고 있습니다.

유럽 가금류 백신 시장 개요

독일에서는 가금질환의 발생이 현저하게 증가하고 있습니다. 1,000마리 이상의 들새에 영향을 주었습니다. 또한, 뉴캐슬병에 대한 백신 접종은 풀어 놓은 새의 집단에 이 바이러스가 많은 독일과 같은 나라에서는 매우 중요한 방역 대책입니다. 예방접종 상설수의위원회(StIKo Vet)은 현재 백신의 제품 특성 개요(SPC) 에 따라 6 주마다 약독생 백신을 식용수 또는 스프레이로 닭에 재접종하는 것이 좋습니다. " "웅형제 병아리"나 혼혈병의 사육중에 아이메리아속이 생산하는 콕시디아증의 발생을 예방·관리하기 위해서 중요한 관행입니다. 따라서, 이러한 모든 요인이 독일의 가금용 백신 시장의 성장에 기여해 있습니다.

유럽 가금류 백신 시장의 수익과 2031년까지의 예측(단위: 100만 달러)

유럽 가금류 백신 시장 세분화

유럽 가금류 백신 시장은 유형, 기술, 복용 형태, 질병, 투여 경로, 최종 사용자, 국가로 분류됩니다.

유형별로 유럽 가금류 백신 시장은 육계와 레이어로 2분화됩니다.

기술적 측면에서 유럽의 가금류 백신 시장은 약독생 백신, 불활화 백신, 재조합 백신으로 분류됩니다.

제형별로, 유럽 가금류 백신 시장은 액체 백신, 동결건조 백신, 분진/분말 백신으로 구분됩니다. 2023년에는 액체 백신이 가장 큰 시장 점유율을 차지했습니다.

질병별로 유럽 가금류 백신 시장은 조류 인플루엔자, 전염성 기관지염, 말렉병, 조류 살모넬라증, 전염성 활액포염(IBD), 뉴캐슬병 등으로 분류됩니다. 조류 독감 분야는 2023년에 가장 큰 시장 점유율을 차지했습니다.

투여 경로별로 유럽의 가금류 백신 시장은 식수(D/W), 근육내 투여(I/M), 피하 투여(I/S), 기타 기타로 구분됩니다. 식수(D/W) 부문은 2023년에 가장 큰 시장 점유율을 차지했습니다.

최종 사용자별로 유럽 가금류 백신 시장은 가금류 및 부화장, 동물 병원, 가금류 백신 접종 시설 및 클리닉으로 구분됩니다. 양계장 부화장 부문이 2023년 최대 시장 점유율을 차지했습니다.

국가별로 유럽 가금류 백신 시장은 독일, 스페인, 프랑스, 영국, 이탈리아 및 기타 유럽으로 구분됩니다. 2023년 유럽 가금류 백신 시장 점유율은 독일이 독점하고 있습니다.

Boehringer Ingelheim International GmbH, Zoetis Inc, BIOVAC, Phybro Animal Health Corp, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, Vaccinova AB.는 유럽 가금류 백신 시장에서 사업을 전개하는 주요 기업입니다.

시장 성장 촉진요인
- 가금질환의 보급 침투
- 가금산업의 성장
시장 성장 억제요인
- 예방접종 실패와 부적절한 취급
시장 기회
- 대량 백신접종에 대한 정부의 지원과 혁신적인 체계
향후의 동향
- 벡터 백신 및 혼합 백신의 진보
성장 촉진요인과 억제요인의 영향

제5장 유럽 가금류 백신 시장 분석

가금용 백신 시장 수익(2021-2031년)

제6장 유럽 가금용 백신 시장 분석 : 유형별

육계(육용 닭)
레이어(계란용 닭)

제7장 유럽 가금용 백신 시장 분석 : 기술별

생백신
불활화 백신
재조합 백신

제8장 유럽의 가금용 백신 시장의 분석 : 제형별

액체 백신
동결 건조 백신
분말 백신

제9장 유럽의 가금용 백신 시장 분석 : 질환별

조류 인플루엔자
새 살모넬라증
말렉병
감염성 기관지염(IB)
감염성 활액포염(IBD)
뉴캐슬병
기타

제10장 유럽의 가금용 백신 시장 분석 : 투여 경로별

식수(D/W)
근육내 투여(I/M)
피하 투여(S/C)
기타

제11장 유럽 가금류 백신 시장 분석 : 최종 사용자별

양계장
동물병원
가금용 백신 접종 센터, 진료소

제12장 유럽 가금용 백신 시장 : 국가별 분석

유럽 시장 개요
- 독일
- 스페인
- 프랑스
- 영국
- 이탈리아
- 기타 유럽

제13장 업계 정세

가금용 백신 시장에서의 성장 전략
유기적 전개
무기적 전개

제14장 기업 프로파일

Boehringer Ingelheim International GmbH
Zoetis Inc
Phibro Animal Health Corp
Dechra Pharmaceuticals PLC
Elanco Animal Health Inc
Merck KGaA
Ceva
Vaccinova AB

제15장 부록

JHS 24.12.04

The Europe poultry vaccines market was valued at US$ 321.82 million in 2023 and is expected to reach US$ 635.01 million by 2031; it is estimated to record a CAGR of 8.9% from 2023 to 2031.

Growing Poultry Industry Drives Europe Poultry Vaccines Market

According to the US Department of Agriculture (USDA) report, poultry has become the most consumed livestock commodity worldwide in the past two decades, particularly in developing and emerging markets. Also, poultry is expected to remain the world's largest imported livestock commodity by volume in the next 10 years as per the same USDA report. The demand for poultry products and imports is rising worldwide. As rising disposable incomes, consumers shift toward purchasing animal-based poultry products comprising high content of proteins, specifically chicken. With rapid urbanization in many developing economies and emerging markets such as Southeast Asia and Sub-Saharan Africa, poultry products provide consumers with an affordable option for purchase as poultry products comprise high protein content and are more readily available as compared to other meat-based products that are expensive. To match the demand and supply of poultry products, several countries are focusing on domestic poultry production. These countries include the US, Brazil, the European Union (EU), and Thailand, which are also major poultry exporters. According to the Council on Foreign Relations 2024 report, the US, Brazil, the European Union, and Thailand account for 71% of the world's poultry exports in 2021. Further, from 2001 to 2021, global poultry imports rose to an average of 4% year-on-year (y-o-y), reaching 14.2 million metric tons of production in 2021. With poultry products remaining high in demand worldwide and countries focusing on domestic livestock production, the demand for vaccination is also growing. Thus, the growing poultry industry fuels the poultry vaccines market growth.

Europe Poultry Vaccines Market Overview

In Germany, poultry disease outbreaks are rising significantly. For instance, Germany experienced the largest HPAI outbreak on record between November 2020 and May 2021. The outbreak affected 245 poultry; captive bird farms; and over 1,000 wild birds. Additionally, vaccination against Newcastle Disease is a crucial control measure in countries such as Germany, where the virus is common in the free-ranging bird population. The German Standing Veterinary Committee on Immunization (StIKo Vet) recommends revaccinating chickens every six weeks with attenuated live vaccines via drinking water or spray, following the Summary of Product Characteristics (SPCs) of current vaccines. Furthermore, Eimeria vaccination is an important practice in laying hens, both caged and free-range birds, to prevent and manage the possibility of suffering an outbreak of coccidiosis produced by Eimeria spp. during the rearing of "male brother chicks" of the layer breeds and mixed genetics chicks. Therefore, all these factors are contributing to the growth of the poultry vaccines market in Germany.

Europe Poultry Vaccines Market Revenue and Forecast to 2031 (US$ Million)

Europe Poultry Vaccines Market Segmentation

The Europe poultry vaccines market is categorized into type, technology, dosage form, disease, route of administration, end user, and country.

Based on type, the Europe poultry vaccines market is bifurcated into broiler and layer. The broiler segment held a larger market share in 2023.

In terms of technology, the Europe poultry vaccines market is categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share in 2023.

By dosage form, the Europe poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held the largest market share in 2023.

Based on disease, the Europe poultry vaccines market is categorized into avian influenza, infectious bronchitis, Marek's disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment held the largest market share in 2023.

In terms of route of administration, the Europe poultry vaccines market is segmented into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held the largest market share in 2023.

Based on end user, the Europe poultry vaccines market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held the largest market share in 2023.

By country, the Europe poultry vaccines market is segmented into Germany, Spain, France, the UK, Italy, and the Rest of Europe. Germany dominated the Europe poultry vaccines market share in 2023.

Boehringer Ingelheim International GmbH, Zoetis Inc, BIOVAC, Phibro Animal Health Corp, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, and Vaccinova AB. are some of the leading companies operating in the Europe poultry vaccines market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

4. Europe Poultry Vaccines Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Rising Prevalence of Poultry Diseases
- 4.1.2 Growing Poultry Industry
4.2 Market Restraints
- 4.2.1 Vaccination Failure and Improper Handling
4.3 Market Opportunities
- 4.3.1 Government Support for Mass Vaccination Drives and Innovative Schemes
4.4 Future Trends
- 4.4.1 Advancements in Vectored and Combination Vaccines
4.5 Impact of Drivers and Restraints:

5. Europe Poultry Vaccines Market Analysis

5.1 Poultry Vaccines Market Revenue (US$ Million), 2021-2031

6. Europe Poultry Vaccines Market Analysis - by Type

6.1 Overview
6.2 Broiler
- 6.2.1 Overview
- 6.2.2 Broiler: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Layer
- 6.3.1 Overview
- 6.3.2 Layer: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

7. Europe Poultry Vaccines Market Analysis - by Technology

7.1 Overview
7.2 Live Attenuated Vaccines
- 7.2.1 Overview
- 7.2.2 Live Attenuated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Inactivated Vaccines
- 7.3.1 Overview
- 7.3.2 Inactivated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Recombinant Vaccines
- 7.4.1 Overview
- 7.4.2 Recombinant Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Poultry Vaccines Market Analysis - by Dosage Form

8.1 Overview
8.2 Liquid Vaccines
- 8.2.1 Overview
- 8.2.2 Liquid Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Freeze-Dried Vaccines
- 8.3.1 Overview
- 8.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Dust/Powdered Vaccines
- 8.4.1 Overview
- 8.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Poultry Vaccines Market Analysis - by Disease

9.1 Overview
9.2 Avian Influenza
- 9.2.1 Overview
- 9.2.2 Avian Influenza: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Avian Salmonellosis
- 9.3.1 Overview
- 9.3.2 Avian Salmonellosis: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Marek's Disease
- 9.4.1 Overview
- 9.4.2 Marek's Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Infectious Bronchitis (IB)
- 9.5.1 Overview
- 9.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.6 Infectious Bursal Disease (IBD)
- 9.6.1 Overview
- 9.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.7 Newcastle Disease
- 9.7.1 Overview
- 9.7.2 Newcastle Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.8 Others
- 9.8.1 Overview
- 9.8.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

10. Europe Poultry Vaccines Market Analysis - by Route of Administration

10.1 Overview
10.2 Drinking Water (D/W)
- 10.2.1 Overview
- 10.2.2 Drinking Water (D/W): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Intramuscular (I/M)
- 10.3.1 Overview
- 10.3.2 Intramuscular (I/M): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Subcutaneous (S/C)
- 10.4.1 Overview
- 10.4.2 Subcutaneous (S/C): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Others
- 10.5.1 Overview
- 10.5.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

11. Europe Poultry Vaccines Market Analysis - by End User

11.1 Overview
11.2 Poultry Farms
- 11.2.1 Overview
- 11.2.2 Poultry Farms: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Veterinary Hospitals
- 11.3.1 Overview
- 11.3.2 Veterinary Hospitals: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Poultry Vaccination Centers & Clinics
- 11.4.1 Overview
- 11.4.2 Poultry Vaccination Centers & Clinics: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

12. Europe Poultry Vaccines Market - Country Analysis

12.1 Europe Market Overview
- 12.1.1 Poultry Vaccines Market Revenue and Forecast and Analysis - by Country
  - 12.1.1.1 Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.1.1 Overview
    - 12.1.1.1.2 Germany: Poultry Vaccines Market Breakdown by Type
    - 12.1.1.1.3 Germany: Poultry Vaccines Market Breakdown by Technology
    - 12.1.1.1.4 Germany: Poultry Vaccines Market Breakdown by Dosage Form
    - 12.1.1.1.5 Germany: Poultry Vaccines Market Breakdown by Disease
    - 12.1.1.1.6 Germany: Poultry Vaccines Market Breakdown by Route of Administration
    - 12.1.1.1.7 Germany: Poultry Vaccines Market Breakdown by End User
  - 12.1.1.2 Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.2.1 Overview
    - 12.1.1.2.2 Spain: Poultry Vaccines Market Breakdown by Type
    - 12.1.1.2.3 Spain: Poultry Vaccines Market Breakdown by Technology
    - 12.1.1.2.4 Spain: Poultry Vaccines Market Breakdown by Dosage Form
    - 12.1.1.2.5 Spain: Poultry Vaccines Market Breakdown by Disease
    - 12.1.1.2.6 Spain: Poultry Vaccines Market Breakdown by Route of Administration
    - 12.1.1.2.7 Spain: Poultry Vaccines Market Breakdown by End User
  - 12.1.1.3 France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.3.1 Overview
    - 12.1.1.3.2 France: Poultry Vaccines Market Breakdown by Type
    - 12.1.1.3.3 France: Poultry Vaccines Market Breakdown by Technology
    - 12.1.1.3.4 France: Poultry Vaccines Market Breakdown by Dosage Form
    - 12.1.1.3.5 France: Poultry Vaccines Market Breakdown by Disease
    - 12.1.1.3.6 France: Poultry Vaccines Market Breakdown by Route of Administration
    - 12.1.1.3.7 France: Poultry Vaccines Market Breakdown by End User
  - 12.1.1.4 United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.4.1 Overview
    - 12.1.1.4.2 United Kingdom: Poultry Vaccines Market Breakdown by Type
    - 12.1.1.4.3 United Kingdom: Poultry Vaccines Market Breakdown by Technology
    - 12.1.1.4.4 United Kingdom: Poultry Vaccines Market Breakdown by Dosage Form
    - 12.1.1.4.5 United Kingdom: Poultry Vaccines Market Breakdown by Disease
    - 12.1.1.4.6 United Kingdom: Poultry Vaccines Market Breakdown by Route of Administration
    - 12.1.1.4.7 United Kingdom: Poultry Vaccines Market Breakdown by End User
  - 12.1.1.5 Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.5.1 Overview
    - 12.1.1.5.2 Italy: Poultry Vaccines Market Breakdown by Type
    - 12.1.1.5.3 Italy: Poultry Vaccines Market Breakdown by Technology
    - 12.1.1.5.4 Italy: Poultry Vaccines Market Breakdown by Dosage Form
    - 12.1.1.5.5 Italy: Poultry Vaccines Market Breakdown by Disease
    - 12.1.1.5.6 Italy: Poultry Vaccines Market Breakdown by Route of Administration
    - 12.1.1.5.7 Italy: Poultry Vaccines Market Breakdown by End User
  - 12.1.1.6 Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.6.1 Overview
    - 12.1.1.6.2 Rest of Europe: Poultry Vaccines Market Breakdown by Type
    - 12.1.1.6.3 Rest of Europe: Poultry Vaccines Market Breakdown by Technology
    - 12.1.1.6.4 Rest of Europe: Poultry Vaccines Market Breakdown by Dosage Form
    - 12.1.1.6.5 Rest of Europe: Poultry Vaccines Market Breakdown by Disease
    - 12.1.1.6.6 Rest of Europe: Poultry Vaccines Market Breakdown by Route of Administration
    - 12.1.1.6.7 Rest of Europe: Poultry Vaccines Market Breakdown by End User

13. Industry Landscape

13.1 Overview
13.2 Growth Strategies in the Poultry Vaccines Market
13.3 Organic Developments
- 13.3.1 Overview
13.1 Inorganic Developments
- 13.1.1 Overview

14. Company Profiles

14.1 Boehringer Ingelheim International GmbH
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Zoetis Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Phibro Animal Health Corp
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Dechra Pharmaceuticals PLC
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Elanco Animal Health Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Merck KGaA
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Ceva
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Vaccinova AB
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms